English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  52724035    ???header.onlineuser??? :  577
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"yeh k h"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 131-155 of 753  (31 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-09-01T02:02:27Z High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection Liang J.-T.; Huang K.-C.; Lai H.-S.; Lee P.-H.; Cheng Y.-M.; Hsu H.-C.; ANN-LII CHENG; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; Tang C.; Chang K.-J.
臺大學術典藏 2021-09-01T02:02:26Z A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil Hsu C.-H.; ANN-LII CHENG; Hsu C.; Yang C.-H.; Lu Y.-S.; Lin C.-C.; Bu C.-F.; Yeh K.-H.
臺大學術典藏 2021-09-01T02:02:24Z Involvement of nuclear transcription factor-κB in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells Yeh P.Y.; Chuang S.-E.; Yeh K.-H.; Song Y.C.; ANN-LII CHENG
臺大學術典藏 2021-09-01T02:02:22Z Recent advances in therapy for gastric cancer Yeh K.-H.; ANN-LII CHENG
臺大學術典藏 2021-09-01T02:02:22Z Down-regulation of thymidylate synthase expression and its steady-state mRNA by oxaliplatin in colon cancer cells Yeh K.-H.; ANN-LII CHENG; Wan J.-P.; Lin C.-S.; Liu C.-C.
臺大學術典藏 2021-09-01T02:02:22Z High-dose Tamoxifen Modulates Drug Resistance to Doxorubicin, Dacarbazine and Ifosfamide in Metastatic Uterine Leiomyosarcoma Yeh K.-H.; Lu Y.-S.; Hsiao C.-H.; ANN-LII CHENG
臺大學術典藏 2021-09-01T02:02:21Z Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract Hsu C.; Shen Y.-C.; Yang C.-H.; Yeh K.-H.; Lu Y.-S.; Hsu C.-H.; Liu H.-T.; Li C.-C.; Chen J.-S.; Wu C.-Y.; ANN-LII CHENG
臺大學術典藏 2021-09-01T02:02:21Z Phase II study of combination doxorubicin, interferon-α, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma Lu Y.-S.; Hsu C.; Li C.-C.; Kuo S.-H.; Yeh K.-H.; Yang C.-H.; Hsu C.-H.; Wu C.-Y.; ANN-LII CHENG
臺大學術典藏 2021-09-01T02:02:21Z Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death Yeh P.Y.; Chuang S.-E.; Yeh K.-H.; Song Y.C.; Chang L.L.-Y.; ANN-LII CHENG
臺大學術典藏 2021-09-01T02:02:20Z Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-κB activation by protein phosphatase 4-mediated NF-κB p 65 Thr dephosphorylation Yeh P.Y.; Yeh K.-H.; Chuang S.-E.; Song Y.C.; ANN-LII CHENG
臺大學術典藏 2021-09-01T02:02:19Z Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas Kuo S.-H.; Chen L.-T.; Yeh K.-H.; Wu M.-S.; Hsu H.-C.; Yeh P.-Y.; Mao T.-L.; Chen C.-L.; Doong S.-L.; Lin J.-T.; ANN-LII CHENG
臺大學術典藏 2021-09-01T02:02:19Z Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer Chao Y.; Yeh K.H.; Chang C.J.; Chen L.T.; Chao T.Y.; Wu M.F.; Chang C.S.; Chang J.Y.; Chung C.Y.; Kao W.Y.; Hsieh R.K.; ANN-LII CHENG
臺大學術典藏 2021-09-01T02:02:18Z Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer Yeh K.H.; Lu Y.S.; Hsu C.H.; Lin J.F.; Chao H.J.; Huang T.C.; Chung C.Y.; Chang C.S.; Yang C.H.; ANN-LII CHENG
臺大學術典藏 2021-09-01T02:02:17Z Expression of CD86 and increased inflitration of NK cells are associated with Helicobacter pylori-dependent state of early stage high-grade gastric MALT lymphoma Kuo S.-H.; Chen L.-T.; Chen C.-L.; Doong S.-L.; Yeh K.-H.; Wu M.-S.; Mao T.-L.; Hsu H.-C.; Wang H.-P.; Lin J.-T.; ANN-LII CHENG
臺大學術典藏 2021-09-01T02:02:16Z Somatic mutations in epidermal growth factor receptor underlying complete responsiveness to gefitinib in a Taiwanese female patient with metastatic adenocarcinoma of lung Yeh K.-H.; Yeh S.-H.; Wan J.-P.; Shen Y.-C.; ANN-LII CHENG
臺大學術典藏 2021-09-01T02:02:16Z Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21 ) Yeh K.-H.; Kuo S.-H.; Chen L.-T.; Mao T.-L.; Doong S.-L.; Wu M.-S.; Hsu H.-C.; Tzeng Y.-S.; Chen C.-L.; Lin J.-T.; ANN-LII CHENG
臺大學術典藏 2021-09-01T02:02:15Z Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment Yang C.-H.; Chen M.-C.; ANN-LII CHENG; Hsu C.-H.; Yeh K.-H.; Yu Y.-C.; Whang-Peng J.; Yang P.-C.
臺大學術典藏 2021-09-01T02:02:15Z Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer Yeh K.-H.; Lu Y.-S.; Hsu C.-H.; Lin J.-F.; Hsu C.; Kuo S.-H.; Li Jr. S.; ANN-LII CHENG
臺大學術典藏 2021-09-01T02:02:14Z Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors Lu Y.-S.; Lien H.-C.; Yeh P.-Y.; Yeh K.-H.; Kuo M.-L.; Kuo S.-H.; ANN-LII CHENG
臺大學術典藏 2021-09-01T02:02:12Z A pathway for tumor necrosis factor-α-induced Bcl10 nuclear translocation: Bcl10 is up-regulated by NF-κB and phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus Pei Y.Y.; Kuo S.-H.; Yeh K.-H.; Chuang S.-E.; Hsu C.-H.; Wen C.C.; Lin H.-I.; Gao M.; ANN-LII CHENG
臺大學術典藏 2021-09-01T02:02:10Z An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer Chao Y.; Li C.P.; Chao T.Y.; Su W.C.; Hsieh R.K.; Wu M.F.; Yeh K.H.; Kao W.Y.; Chen L.T.; ANN-LII CHENG
臺大學術典藏 2021-09-01T02:02:09Z Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer Lin C.-C.; Hsu C.-H.; Cheng J.C.; Wang H.-P.; Lee J.-M.; Yeh K.-H.; Yang C.-H.; Lin J.-T.; ANN-LII CHENG; Lee Y.-C.
臺大學術典藏 2021-09-01T02:02:08Z A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer Lin C.-C.; ANN-LII CHENG; Hsu C.-H.; Lu Y.-S.; Hsu C.; Yeh K.-H.; Wu C.-Y.; Huang C.-S.; Yang C.-H.
臺大學術典藏 2021-09-01T02:02:07Z Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach - Significance of tumour cell clonality and BCL10 expression Kuo S.-H.; Chen L.-T.; Wu M.-S.; Kuo K.-T.; Yeh K.-H.; Doong S.-L.; Yeh P.-Y.; Hsu H.-C.; Tzeng Y.-S.; Lin C.-W.; Lin J.-T.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:32Z Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma Lin C.-C.; Yeh K.-H.; Yang C.-H.; Hsu C.; Tsai Y.-C.; Hsu W.-L.; ANN-LII CHENG; Hsu C.-H.

Showing items 131-155 of 753  (31 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page